18 /100
LOW RISK
Score updated May 28, 2026

VRTX — Vertex Pharmaceuticals Incorporated Dilution Risk Tracker

Track VRTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VRTX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 8 points (worsening)
🔔 Track VRTX — Get forecast alerts →

💹 Market Data

Market Cap$113.29B
Shares Outstanding253.81M
Float253.02M
Cash$7.25B
Debt$105.00M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 3.8% shares (2025Q4 vs prior)
1644 institutional holders · 245.21M shares
#1 Capital World Investors 25.51M shares
#2 VANGUARD GROUP INC 24.11M shares
#3 BlackRock, Inc. 23.75M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.17M
Days to Cover4.3
% of Float1.6%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2013
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Apr 17, 2026
4 INSIDER TRANSACTION Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track VRTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VRTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for VRTX
📊 VRTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 VRTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.